Resistance Training Is the Most Underrated Longevity Drug (Here's the Dose)
By Akash S. Chauhan | First Principles Healthspan, Issue 12
The gym bros had the right answer for the wrong reasons. Progressive overload is not about aesthetics. It is not about the mirror or the beach or the performance review of your physique. It is about surviving the back half of your life with your independence intact. Muscle does not just look good — it is metabolically active tissue that processes glucose, cushions falls, protects joints, determines whether you can get off the floor without help at age 80, and, according to the mortality literature, predicts whether you will live long enough to worry about any of the rest of this.
Why this matters
Ask a group of health-conscious professionals how they structure their week, and the distribution is remarkably consistent: four to six hours of cardio — running, cycling, zone 2 — and zero to one hour of resistance training. That ratio is almost exactly backwards relative to what the longevity evidence supports. Aerobic fitness is genuinely important and we have covered VO2max in a previous issue. But the mortality signal attached to muscular strength is at least as strong as the aerobic fitness signal, and in some analyses it is stronger — particularly after age 50, when sarcopenic decline begins to accelerate and the consequences of low muscle mass compound rapidly.
If you are doing four hours of cardio and one hour of lifting per week, you are not being lazy — you are being selectively attentive to about half the evidence.
The Mortality Signal: What the Strength Studies Show
The foundational paper in this area is Ruiz et al. (2008), published in BMJ, which followed approximately 9,000 men over a median of 18.9 years (PMID: 18595904). The study measured muscular strength directly — upper body via bench press, lower body via leg press — and then tracked mortality outcomes. The finding: men in the lowest third of muscular strength had significantly higher rates of all-cause mortality and cancer mortality compared to men in the highest third, and this relationship held after adjusting for cardiorespiratory fitness, body fat, smoking, alcohol, and family history.
What made this study particularly notable was that the strength-mortality relationship held independently of aerobic fitness. You could not buy your way out of weak muscles by running. The two variables contributed independently to mortality risk, which means a high VO2max and low muscle mass leaves a gap in your protection that aerobic training cannot fill.
Kamada et al. (2017), in JAMA Internal Medicine, extended this to a dose-response analysis (PMID: 27599729). They examined muscle-strengthening activity — not gym records, just self-reported resistance training frequency — and tracked mortality outcomes in a large prospective cohort. The curve was clear: mortality risk fell progressively as resistance training frequency increased from zero sessions per week up to roughly two sessions per week, where the benefit-to-effort curve began to flatten. The dose-response shape matters because it tells you where the biggest returns are: going from zero to two sessions per week captures the majority of the mortality benefit.
Liberman et al. (2021), in JAMA Network Open, found that resistance training at two or more sessions per week was associated with a 29% lower all-cause mortality risk compared to no resistance training, even after controlling for aerobic activity. Twenty-nine percent is a large absolute risk reduction for a behavioral intervention, and it is entirely absent in people doing exclusively aerobic exercise without any resistance component.
The 45-Year-Old Floor Test
There is a simple functional test that requires no equipment, no lab, and no appointment. Sit down cross-legged on the floor. Now stand back up — without using your hands, forearms, or knees for support. This is sometimes called the sit-to-stand test or floor rise test, and a study in the European Journal of Preventive Cardiology (Brito et al., 2012) found that performance on this test predicted all-cause mortality in adults over 51 years of age, with each unit decrease in score associated with a 21% increase in mortality risk.
The test is not magic. It captures a composite of lower body strength, mobility, flexibility, and neuromuscular coordination — the exact physical capacities that determine whether a fall at 75 ends in a five-minute inconvenience or a catastrophic hospitalization. Try it now. If you cannot do it cleanly, that is not a character judgment — it is a gap in the physical preparation your future self is going to need.
The practical reality is that the strength and mobility required to pass that test comfortably are built over years, not months. The professionals who will have that capacity at 70 are the ones who started progressive loading at 40 or 45, not the ones who planned to "start lifting eventually" until it was structurally too late to build the tissue.
The Dose: Minimum Effective vs. Optimal
The mortality data supports a minimum effective dose of two full-body resistance training sessions per week. Two sessions. The Kamada and Liberman analyses both converge on this threshold as the point where significant risk reduction is realized. For most professionals currently doing zero or one session per week, getting to two is the intervention with the clearest evidence-based payoff.
Optimal, for the purposes of muscle hypertrophy and strength development, sits at three to four sessions per week — enough frequency to hit each major muscle group twice per week, which the hypertrophy literature identifies as the training frequency with the best evidence for long-term muscle development. The distinction between minimum effective and optimal is practically important: if you are a busy professional with limited time, two full-body sessions per week will capture most of the longevity benefit. Chasing four sessions when you can only sustain two leads to dropout, which captures none of the benefit.
What counts as resistance training for these purposes: any progressive loading that challenges the major muscle groups — deadlifts, squats, rows, presses, lunges. The form of implementation matters less than the progressive overload principle: each week, or each month, you are lifting slightly more, moving slightly more volume, or doing the same load with better quality. Without progression, adaptation stalls. Without adaptation, you are maintaining at best and losing to age at worst.
The Metabolic Case Beyond Mortality
The mortality signal is the headline, but muscle tissue has metabolic functions that deserve their own paragraph. Skeletal muscle is the largest insulin-sensitive tissue in the body by mass. When you have more of it and it is regularly contracted, it acts as a glucose disposal reservoir — pulling blood sugar out of circulation through both insulin-dependent and insulin-independent mechanisms. This is why resistance training has a well-documented effect on improving insulin sensitivity that is partially independent of the effect of aerobic training and partially additive to it.
Muscle also has endocrine function. Contracting muscle secretes myokines — IL-6, irisin, BDNF precursors, and others — that have anti-inflammatory effects, promote neuroplasticity, and appear to mediate some of the cognitive benefits associated with exercise. The exercise-cognition literature increasingly suggests that resistance training, not just aerobic exercise, has measurable effects on executive function and memory in middle-aged and older adults. That is not an argument to stop running. It is an argument to stop treating the gym as a secondary or optional activity relative to cardio.
For anyone starting or returning to resistance training, creatine monohydrate is worth mentioning here because it directly supports the training adaptations we are trying to drive. The evidence base is decades deep and the cost is negligible. I use the Momentous creatine and protein stack — the creatine supports ATP resynthesis for high-intensity efforts, and the protein closes the dietary gap on muscle protein synthesis. Neither is a substitute for the training itself. Both are small levers that, applied consistently, compound meaningfully over months.
This Week's One Thing to Do
Add one heavy compound movement to your next workout. A deadlift or a squat — your choice. If you have not done either in months or years, start conservatively: a Romanian deadlift with dumbbells or a goblet squat works perfectly well and poses lower technical complexity than a barbell movement from a cold start. The specific exercise matters far less than the principle: load a large muscle group through a full range of motion, with enough weight that the last two reps of your set require genuine effort.
Then do it again next week.
That is it. Not a full program. Not a periodization scheme. One compound movement, twice per week, progressively loaded. That is the minimum viable version of the intervention with a 29% mortality risk reduction attached to it.
Until next week, Akash S. Chauhan
Education only. Not medical advice. Always consult a licensed clinician for individual decisions.